JP2013501796A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501796A5
JP2013501796A5 JP2012524789A JP2012524789A JP2013501796A5 JP 2013501796 A5 JP2013501796 A5 JP 2013501796A5 JP 2012524789 A JP2012524789 A JP 2012524789A JP 2012524789 A JP2012524789 A JP 2012524789A JP 2013501796 A5 JP2013501796 A5 JP 2013501796A5
Authority
JP
Japan
Prior art keywords
delivery device
drug delivery
subject
migraine
score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012524789A
Other languages
English (en)
Japanese (ja)
Other versions
JP6116246B2 (ja
JP2013501796A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/045045 external-priority patent/WO2011019732A1/en
Publication of JP2013501796A publication Critical patent/JP2013501796A/ja
Publication of JP2013501796A5 publication Critical patent/JP2013501796A5/ja
Application granted granted Critical
Publication of JP6116246B2 publication Critical patent/JP6116246B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012524789A 2009-08-10 2010-08-10 イオントフォレシスにより悪心および片頭痛を治療するための方法 Active JP6116246B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US23261709P 2009-08-10 2009-08-10
US61/232,617 2009-08-10
US25679609P 2009-10-30 2009-10-30
US61/256,796 2009-10-30
US35830010P 2010-06-24 2010-06-24
US61/358,300 2010-06-24
PCT/US2010/045045 WO2011019732A1 (en) 2009-08-10 2010-08-10 Methods for iontophoretically treating nausea and migraine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015150968A Division JP2016014028A (ja) 2009-08-10 2015-07-30 イオントフォレシスにより悪心および片頭痛を治療するための方法

Publications (3)

Publication Number Publication Date
JP2013501796A JP2013501796A (ja) 2013-01-17
JP2013501796A5 true JP2013501796A5 (OSRAM) 2013-09-19
JP6116246B2 JP6116246B2 (ja) 2017-04-19

Family

ID=43586432

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012524789A Active JP6116246B2 (ja) 2009-08-10 2010-08-10 イオントフォレシスにより悪心および片頭痛を治療するための方法
JP2015150968A Pending JP2016014028A (ja) 2009-08-10 2015-07-30 イオントフォレシスにより悪心および片頭痛を治療するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015150968A Pending JP2016014028A (ja) 2009-08-10 2015-07-30 イオントフォレシスにより悪心および片頭痛を治療するための方法

Country Status (11)

Country Link
US (2) US8845612B2 (OSRAM)
EP (1) EP2464234A4 (OSRAM)
JP (2) JP6116246B2 (OSRAM)
CN (3) CN105796533A (OSRAM)
AU (1) AU2010282660B2 (OSRAM)
BR (1) BR112012003111A8 (OSRAM)
CA (1) CA2770211A1 (OSRAM)
EA (1) EA201270227A1 (OSRAM)
IL (1) IL217935A0 (OSRAM)
NZ (1) NZ598622A (OSRAM)
WO (1) WO2011019732A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
JP6116246B2 (ja) 2009-08-10 2017-04-19 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー イオントフォレシスにより悪心および片頭痛を治療するための方法
US9918932B2 (en) 2016-02-19 2018-03-20 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
WO2017152130A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5651768A (en) 1983-08-18 1997-07-29 Drug Delivery Systems, Inc. Transdermal drug applicator and electrodes therefor
US5605536A (en) 1983-08-18 1997-02-25 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4822802A (en) 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5207752A (en) 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
DE4014913C2 (de) 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
ES2112552T3 (es) 1992-06-02 1998-04-01 Alza Corp Dispositivo para la administracion de un medicamento por electrotransporte.
US5807571A (en) * 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
DE69429603T2 (de) 1993-09-22 2002-08-14 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
PT836511E (pt) 1995-06-05 2004-08-31 Alza Corp Dispositivo para distribuicao de fentanilo e sufentanilo por electrotransporte percutaneo
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5941843A (en) 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5882677A (en) 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
SE9802864D0 (sv) 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
US6421561B1 (en) 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
IT1319210B1 (it) 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
ATE404193T1 (de) * 2001-06-05 2008-08-15 Ronald Aung-Din Topische migränetherapie
US6975902B2 (en) 2002-06-28 2005-12-13 Alza Corporation Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
RU2326893C2 (ru) 2003-04-16 2008-06-20 Кориум Интернэшнл Ковалентное и нековалентное сшивание гидрофильных полимеров и адгезивные композиции, полученные с ними
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
WO2007041434A2 (en) 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis apparatus and method for delivery of angiogenic factors to enhance healing of injured tissue
KR20080058432A (ko) 2005-09-30 2008-06-25 티티아이 엘뷰 가부시키가이샤 활성 약제의 전신 전달을 위한 이온삼투 방법 및 장치
BRPI0709965C2 (pt) * 2006-04-13 2011-12-20 Nupathe Inc formulações melhoradas de poliamina para a iontoforese do composto triptano
US8155737B2 (en) * 2008-06-19 2012-04-10 Nupathe, Inc. Pharmacokinetics of iontophoretic sumatriptan administration
US8366600B2 (en) 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
JP6116246B2 (ja) 2009-08-10 2017-04-19 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー イオントフォレシスにより悪心および片頭痛を治療するための方法

Similar Documents

Publication Publication Date Title
JP2013501796A5 (OSRAM)
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2011041478A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
WO2008061625A3 (de) Transdermales therapeutisches system zur verabreichung des wirkstoffs buprenorphin
JP2013522184A5 (OSRAM)
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
MX2014004548A (es) Metodos para tratar pacientes pediatricos usando dexmedetomidina.
JP2010059183A5 (OSRAM)
JP2013522303A5 (OSRAM)
MX344329B (es) Formulación de una combinación de dronedarona y ranolazina para la manufactura de un medicamento para tratar fibrilación atrial.
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
WO2012050831A3 (en) Combination treatment for dermatological conditions
WO2010151565A3 (en) Combination therapies for the treatment of obesity
NZ598622A (en) Methods for iontophoretically treating nausea and migraine
RU2009122281A (ru) Средство для лечения заболеваний в ветеринарии на основе соли фосфония
JP2012525358A5 (OSRAM)
JP2011500589A5 (OSRAM)
JP2010519192A5 (OSRAM)
RU2009127776A (ru) Профилактическое или терапевтическое средство от алопеции
MX2012002161A (es) El uso de lapatinib o una sal o composición farmacéuticamente aceptable del mismo para el tratamiento de cancer.
PL1732551T3 (pl) Perheksylina do leczenia przewlekłej niewydolności serca
MX348723B (es) Combinaciones de solifenacina y estimulantes salivales para el tratamiento de la vejiga hiperactiva.
JP2013502449A5 (OSRAM)
WO2011008490A3 (en) Combination therapies for the treatment of obesity
RU2012114097A (ru) Терапевтический агент против хронической боли